PS-47

CAS No. 1180676-33-8

PS-47( PS 47 | PS47 )

Catalog No. M23348 CAS No. 1180676-33-8

PS-47 is an inactive E-isomer of PS48. PS48 is an activator of PDK1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 39 In Stock
10MG 39 In Stock
25MG 84 In Stock
50MG 128 In Stock
100MG 211 In Stock
200MG 299 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PS-47
  • Note
    Research use only, not for human use.
  • Brief Description
    PS-47 is an inactive E-isomer of PS48. PS48 is an activator of PDK1.
  • Description
    PS-47 is an inactive E-isomer of PS48. PS48 is an activator of PDK1.
  • In Vitro
    PS47 shows very low binding affinity or no binding to PDK1 (Kd>200 μM).
  • In Vivo
    ——
  • Synonyms
    PS 47 | PS47
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1180676-33-8
  • Formula Weight
    286.75
  • Molecular Formula
    C17H15ClO2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:90mg/ml(313.86mM; need ultrasonic)
  • SMILES
    OC(/C=C(\CCc(cc1)ccc1Cl)/c1ccccc1)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hindie V , Stroba A , Zhang H , et al. Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1.[J]. Nature Chemical Biology, 2009, 5(10):758.
molnova catalog
related products
  • ZX-J-19J

    ZX-J-19J, an inhibitor of Cyclophilin J (CyPJ), demonstrates remarkable inhibition of tumor cell growth, comparable to cyclosporine A but much stronger than 5-fluorouracil.

  • Isosilybin

    Isosilybin and Silybin might be suitable candidates to design potent PXR antagonists to prevent drug-drug interactions via CYP3A4 in cancer patients.

  • Polysorbate 20

    Polysorbate 20 (Tween-20) ,sorbitan mono-9-octadecanoate poly(oxy-1,2-ethanediyl) derivatives, is used in the formulation of biotherapeutic products for both preventing surface adsorption and as a stabilizer against protein aggregation.